Why the study?
SARS-CoV-2 caused a global pandemic, and its RNA-dependent RNA polymerase (nsp12) is the central component of viral replication machinery and a primary target for remdesivir.
The structure of the SARS-CoV-2 RNA-dependent RNA polymerase provides a basis for the design of new antiviral therapeutics targeting viral RdRp.
Answers are grounded in this paper and cite their sources.
Should not yet alter remdesivir use; leaves open structure-guided design of superior RdRp inhibitors.
A novel coronavirus [severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2)] outbreak has caused a global coronavirus disease 2019 (COVID-19) pandemic, resulting in tens of thousands of infections and thousands of deaths worldwide. The RNA-dependent RNA polymerase [(RdRp), also named nsp12] is the central component of coronaviral replication and transcription machinery, and it appears to be a primary target for the antiviral drug remdesivir. We report the cryo-electron microscopy structure of COVID-19 virus full-length nsp12 in complex with cofactors nsp7 and nsp8 at 2.9-angstrom resolution. In addition to the conserved architecture of the polymerase core of the viral polymerase family, nsp12 possesses a newly identified β-hairpin domain at its N terminus. A comparative analysis model shows how remdesivir binds to this polymerase. The structure provides a basis for the design of new antiviral therapeutics that target viral RdRp.
No takes yet. Share an insight, caveat, or question.
Gao et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: